Lawsuit Over Failure to Prevent Fatal Heart Attack Results in $3.74M Award

|

A medical malpractice lawsuit filed over a fatal heart attack suffered by a Massachusetts, which was allegedly caused by his doctor’s failure to diagnose and properly treat reports of chest pains, has resulted in a $3.74 million jury award. 

The complaint was brought by the family of Robby Lee Ward, who died in 2006 after suffering a heart attack. The defendant in the case was Dr. Peter J. Demartino, Ward’s primary care physician at Acton Medical Associates.

According to allegations raised by the family, the 59 year-old Ward complained of chest pains and was taken by ambulance to Mount Auburn Hospital, where staff failed to diagnose him as suffering a heart attack and released him in February 2006. Afterward, Ward went to see Dr. Demartino, who took him off an aspirin regimen.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Aspirin is regularly prescribed to patients at risk of suffering a heart attack, because of its use as a blood thinner. Not only did Dr. Demartino tell Ward to stop taking aspirin, despite its prophylactic benefits, but he also did not recommend that he see a cardiologist, despite signs that he was suffering some sort of heart problem.

Ward died in June 2006, and an autopsy revealed he had coronary heart disease and had previously suffered heart damage.

Late last month, a jury in Middlesex County Superior Court in Massachusetts determined that Dr. Demartino was negligent in the medical care provided to Ward. Another employee of Acton Medical Associates was cleared by the same jury.

The jury awarded $3.74 million in damages. However, because the case was filed in 2007, the Boston Business Journal reports that final payment to th family could be as much as $5.8 million.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.
A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL.
Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.